Literature DB >> 17109012

Cancer as an evolutionary and ecological process.

Lauren M F Merlo1, John W Pepper, Brian J Reid, Carlo C Maley.   

Abstract

Neoplasms are microcosms of evolution. Within a neoplasm, a mosaic of mutant cells compete for space and resources, evade predation by the immune system and can even cooperate to disperse and colonize new organs. The evolution of neoplastic cells explains both why we get cancer and why it has been so difficult to cure. The tools of evolutionary biology and ecology are providing new insights into neoplastic progression and the clinical control of cancer.

Entities:  

Mesh：

Year:  2006        PMID： 17109012     DOI： 10.1038/nrc2013

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  153 in total

1.  The inference of stepwise changes in substitution rates using serial sequence samples.

Authors:  A Drummond; R Forsberg; A G Rodrigo
Journal:  Mol Biol Evol       Date:  2001-07       Impact factor: 16.240

2.  Evolution of resistance during clonal expansion.

Authors:  Yoh Iwasa; Martin A Nowak; Franziska Michor
Journal:  Genetics       Date:  2006-04       Impact factor: 4.562

3.  Genetic reconstruction of individual colorectal tumor histories.

Authors:  J L Tsao; Y Yatabe; R Salovaara; H J Järvinen; J P Mecklin; L A Aaltonen; S Tavaré; D Shibata
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 4.  Predicting the geography of species' invasions via ecological niche modeling.

Authors:  A Townsend Peterson
Journal:  Q Rev Biol       Date:  2003-12       Impact factor: 4.875

5.  Gestational mutations and carcinogenesis.

Authors:  Rafael Meza; E Georg Luebeck; Suresh H Moolgavkar
Journal:  Math Biosci       Date:  2005-10       Impact factor: 2.144

Review 6.  The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair.

Authors:  Bret S Weinstein; Deborah Ciszek
Journal:  Exp Gerontol       Date:  2002-05       Impact factor: 4.032

Review 7.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

8.  Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.

Authors:  Koichi Fukino; Lei Shen; Satoshi Matsumoto; Carl D Morrison; George L Mutter; Charis Eng
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

9.  Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population.

Authors:  G-Q Wang; C C Abnet; Q Shen; K J Lewin; X-D Sun; M J Roth; Y-L Qiao; S D Mark; Z-W Dong; P R Taylor; S M Dawsey
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205
View more
  590 in total

1.  The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

Authors:  Lauren L C Marotta; Vanessa Almendro; Andriy Marusyk; Michail Shipitsin; Janina Schemme; Sarah R Walker; Noga Bloushtain-Qimron; Jessica J Kim; Sibgat A Choudhury; Reo Maruyama; Zhenhua Wu; Mithat Gönen; Laura A Mulvey; Marina O Bessarabova; Sung Jin Huh; Serena J Silver; So Young Kim; So Yeon Park; Hee Eun Lee; Karen S Anderson; Andrea L Richardson; Tatiana Nikolskaya; Yuri Nikolsky; X Shirley Liu; David E Root; William C Hahn; David A Frank; Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

3.  Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility.

Authors:  C Athena Aktipis; Carlo C Maley; John W Pepper
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

Review 4.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 5.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

6.  Lessons from a decade of integrating cancer copy number alterations with gene expression profiles.

Authors:  Norman Huang; Parantu K Shah; Cheng Li
Journal:  Brief Bioinform       Date:  2011-09-23       Impact factor: 11.622

7.  The ecological basis of morphogenesis: branching patterns in swarming colonies of bacteria.

Authors:  Pan Deng; Laura de Vargas Roditi; Dave van Ditmarsch; Joao B Xavier
Journal:  New J Phys       Date:  2014-01       Impact factor: 3.729

8.  Tumor evolution in response to chemotherapy: phenotype versus genotype.

Authors:  Nicholas E Navin
Journal:  Cell Rep       Date:  2014-02-13       Impact factor: 9.423

Review 9.  Life history trade-offs in cancer evolution.

Authors:  C Athena Aktipis; Amy M Boddy; Robert A Gatenby; Joel S Brown; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2013-11-11       Impact factor: 60.716

10.  Emergence of spatial structure in the tumor microenvironment due to the Warburg effect.

Authors:  Carlos Carmona-Fontaine; Vanni Bucci; Leila Akkari; Maxime Deforet; Johanna A Joyce; Joao B Xavier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.